Max Robotics — Global Service Robot Directory + US Certification

About

Stephanie A. Harmon is a leading researcher in the field of prostate cancer imaging, with a focus on leveraging multiparametric magnetic resonance imaging (mpMRI) to improve surgical planning and patient outcomes. Her most impactful contribution is the development of a novel MRI-based grading system for assessing the risk of extraprostatic extension (EPE) of prostate cancer, published in 2019 and cited over 238 times. This system provides a standardized, non-invasive method to predict tumor spread beyond the prostate, directly influencing decisions on nerve-sparing surgery and reducing positive surgical margins. Harmon also pioneered the integration of mpMRI with virtual reality (VR) technology, creating a surgical navigation tool for robotic-assisted radical prostatectomy (27 citations). This innovative work demonstrates the feasibility of using VR to enhance a surgeon’s spatial understanding of tumor location, potentially improving precision and outcomes. Additionally, she has investigated the impact of neoadjuvant antiandrogen and androgen deprivation therapy on mpMRI staging (8 citations), addressing a critical gap in imaging interpretation for treated patients. Through her research, Harmon has advanced the clinical utility of mpMRI from diagnostic tool to active surgical guide, earning recognition for bridging radiology and urology. Her work continues to shape personalized treatment strategies for prostate cancer patients.